• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Respiratory Drugs Market 2016-2020 with AstraZeneca , Boehringer Ingelheim, F.Hoffman La-Roche, GlaxoSmithKline, Merck & Novartis Dominated - Research and Markets

    Global Respiratory Drugs Market 2016-2020 with AstraZeneca , Boehringer Ingelheim, F.Hoffman La-Roche, GlaxoSmithKline, Merck & Novartis Dominated - Research and Markets

  2. AstraZeneca Reports Positive Results From Asthma Drug Trial

    AstraZeneca Reports Positive Results From Asthma Drug Trial

  3. AstraZeneca Prices Euro Medium-Term Notes at EUR2.20 Billion

    AstraZeneca Prices Euro Medium-Term Notes at EUR2.20 Billion

  4. Correction to AstraZeneca Drug Trial Story

    Correction to AstraZeneca Drug Trial Story

  5. UPDATE: Four reasons for investors to buy biotechnology stocks now

    UPDATE: Four reasons for investors to buy biotechnology stocks now

  6. AstraZeneca PLC AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY

    AstraZeneca PLC AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY

  7. Hidradenitis Suppurativa Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, AstraZeneca , Amgen - Research and Markets

    Hidradenitis Suppurativa Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, AstraZeneca , Amgen - Research and Markets

  8. Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Novartis, Allergan, AstraZeneca - Research and Markets

    Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Novartis, Allergan, AstraZeneca - Research and Markets

  9. Gestational Diabetes Global Clinical Trials Review, H1, 2016 - Key Players are Novo A/S, Eli Lily and Company & AstraZeneca Plc - Research and Markets

    Gestational Diabetes Global Clinical Trials Review, H1, 2016 - Key Players are Novo A/S, Eli Lily and Company & AstraZeneca Plc - Research and Markets

  10. FTSE 100 flops as Burberry earnings, U.S. rate-hike prospects weigh

    FTSE 100 flops as Burberry earnings, U.S. rate-hike prospects weigh

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.